Cardiovascular Diabetology

MARCH 19, 2025

This study aims to identify early metabolomic biomarkers of gestational diabetes mellitus (GDM) and evaluate their association with hepatic steatosis.

Biomarkers 52

Biomarkers Diabetes Research 52

Medical Xpress - Cardiology

JANUARY 2, 2024

A two-step screening protocol that combines clinical risk assessment with biomarker testing can more effectively identify which patients with type 2 diabetes need medication to prevent heart failure, according to a study led by UT Southwestern Medical Center researchers.

Heart Failure 79

Heart Failure Diabetes Biomarkers Research 79

Dr. Paddy Barrett

FEBRUARY 21, 2025

Recent research suggested that the weight loss market was estimated to be worth $224 billion annually in 2021 and is estimated to exceed $400 billion by 2024 1. Type 2 Diabetes When it comes to the increasing the risk of major chronic diseases such as cardiovascular disease, many cancers and dementia, type 2 diabetes plays a huge role.

Obesity 79

Obesity Diabetes Cardiovascular Disease Chronic Disease 79

Cardiovascular Diabetology

NOVEMBER 1, 2024

Dysglycemia and insulin resistance increase type 2 diabetes (T2D) and cardiovascular disease (CVD) risk, yet associations with specific glucose-insulin homeostatic biomarkers have been inconsistent. Vitamin D.

Cardiovascular Disease 52

Cardiovascular Disease Biomarkers Diabetes Research 52

Cardiovascular Diabetology

DECEMBER 17, 2024

Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus and causes vision impairment and blindness. The presence of major risk factors for DR, such as high levels of HbA1c, does no.

Diabetes 59

Diabetes Biomarkers Risk Factors Research 59

Cardiovascular Diabetology

OCTOBER 27, 2024

Systemic stress, inflammation, and hydroelectrolytic and acid‒base abnormalities observed during diabetic ketoacidosis (DKA) can cause changes in the heart and even induce cardiovascular damage. We aimed to ev.

Diabetes 52

Diabetes Biomarkers Research 52

Cardiovascular Diabetology

MARCH 20, 2025

The triglyceride-glucose index serves as a dependable biomarker for gauging insulin resistance linked to cardiovascular disease. Our study was designed to investigate how the trajectory of the triglyceride-glu.

Heart Failure 86

Heart Failure Biomarkers Cardiovascular Disease Diabetes 86

Cardiovascular Diabetology

JANUARY 19, 2024

Type 2 diabetes mellitus (T2DM) increases the risk of coronary heart disease (CHD) by 2–4 fold, and is associated with endothelial dysfunction, dyslipidaemia, insulin resistance, and chronic hyperglycaemia.

Diabetes 69

Diabetes Circulation Biomarkers Heart Disease 69

DAIC

FEBRUARY 1, 2024

In addition, market research firms, like FACTMR referenced here, focused on the cardiology industry and regularly issue insightful reviews and forecasts worthy of note, portions of each shared here. People with diabetes are twice as likely to have heart disease or a stroke than people without diabetes. - In addition, 115.9

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Strokes Stroke 104

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Cardiovascular Diabetology

MARCH 7, 2025

Coronary artery disease (CAD) and diabetes mellitus (DM) can induce changes in myocardial structure and function, thereby increasing the risk of heart failure (HF). We aimed to identify the alterations in echo.

Coronary Artery Disease 52

Coronary Artery Disease Diabetes Biomarkers Heart Failure 52

Cardiovascular Diabetology

MAY 2, 2024

Type 2 Diabetes Mellitus (T2DM) presents a significant healthcare challenge, with considerable economic ramifications. While blood glucose management and long-term metabolic target setting for home care and ou.

Diabetes 52

Diabetes Hospital Biomarkers Research 52

Cardiovascular Diabetology

APRIL 28, 2024

Glycemic control, as measured by glycosylated hemoglobin (HbA1c), is an important biomarker to evaluate diabetes severity and is believed to be associated with heart failure development. Type 2 diabetes mellit.

Heart Failure 52

Heart Failure Diabetes Biomarkers Outcomes 52

Cardiovascular Diabetology

AUGUST 6, 2024

Gestational diabetes mellitus (GDM) significantly impacts maternal and infant health both immediately and over the long term, yet effective early diagnostic biomarkers are currently lacking. Thus, it is essent.

Diabetes 52

Diabetes Biomarkers Research 52

Cardiovascular Diabetology

JANUARY 12, 2025

Diabetic myocardial disorder (DbMD, evidenced by abnormal echocardiography or cardiac biomarkers) is a form of stage B heart failure (SBHF) at high risk for progression to overt HF. SBHF is defined by abnormal.

Diabetes 52

Diabetes Biomarkers Heart Failure Research 52

Circulation

MARCH 9, 2025

Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors. Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025.

Kidney Disease 83

Kidney Disease Biomarkers Heart Failure Risk Factors 83

DAIC

APRIL 9, 2024

The research was presented at the American College of Cardiology ’s Annual Scientific Session. The international ARISE-HF trial was designed to test the effectiveness of the investigational drug AT-001 at stabilizing exercise capacity in patients with diabetic cardiomyopathy.

Heart Failure 52

Heart Failure Diabetes Cardiomyopathy Exercise 52

DAIC

JANUARY 30, 2024

The new model uses a set of 10 factors including age, cigarette smoking status, diabetes status, and blood levels of several cardiac biomarkers, to gauge the risk of a new cardiovascular event, regardless of whether the patient has had one before. Parameters of the new model are available in the paper supplements.

Cardiovascular Disease 52

Cardiovascular Disease Research Heart Attack Heart attacks 52

European Journal of Heart Failure

NOVEMBER 3, 2024

Development and validation of a machine-learning approach to identify diabetic cardiomyopathy. Aims Abnormalities in specific echocardiographic parameters and cardiac biomarkers have been reported among individuals with diabetes. The high-risk DbCM phenotype was identified based on the incidence of HF on follow-up.

Cardiomyopathy 40

Cardiomyopathy Diabetes Biomarkers Atherosclerosis 40

Cardiovascular Diabetology

FEBRUARY 12, 2024

Studies have demonstrated that coronary artery calcification on one hand and non-alcoholic fatty liver disease (NAFLD) on the other hand are strongly associated with cardiovascular events. However, it remains.

Biomarkers 69

Biomarkers Diabetes Research 69

Cardiovascular Diabetology

OCTOBER 13, 2024

Triglyceride (TG) and its related metabolic indices are recognized as important biomarker gauging cardiovascular diseases. This study aimed to explore the association between multiple TG-derived metabolic indi.

Biomarkers 52

Biomarkers Heart Disease Cardiovascular Disease Diabetes 52

Cardiovascular Diabetology

SEPTEMBER 27, 2024

The pericoronary fat attenuation index (FAI) has emerged as a novel and sensitive biomarker reflecting the degree of coronary artery inflammation. Semaglutide has been demonstrated to exert a cardiovascular pr.

Biomarkers 52

Biomarkers Diabetes Research 52

Circulation

NOVEMBER 11, 2024

Background:Peripheral artery disease (PAD) is associated with high morbidity and mortality and is closely related to diabetes mellitus (DM) and atherosclerosis. General population samples from the National Health Research Institutes were used as the control group to compare the methylation status.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Biomarkers Angioplasty Atherosclerosis 40

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Dr. Paddy Barrett

OCTOBER 11, 2024

I have covered this topic previously here , but it is clear that inflammation plays a major role in the initiation and progression of coronary artery disease, and the inflammatory biomarker hsCRP is tightly connected to this process. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. Pharmaceutical Research, Vol.

Obesity 81

Obesity Cancer Dementia Coronary Artery Disease 81

Physiologically Speaking

JANUARY 12, 2024

One of the most promising biomarkers of biological age are so-called DNA methylation-based age estimators, otherwise known as DNA methylation age clocks. Finally, having dyslipidemia (abnormal levels of blood lipids) and diabetes were associated with a higher age acceleration. A recent study provides us with some novel insight.

Physiology 124

Physiology BMI Exercise Diet 124

European Journal of Heart Failure

JANUARY 14, 2025

SGLT2-i, sodiumglucose cotransporter 2 inhibitor; T2D, type 2 diabetes. Sodiumglucose cotransporter 2 inhibitors, a class of anti-diabetic drugs, showed to improve cardiovascular functions although their mechanism of action has not yet been fully established.

Diabetes 40

Diabetes Biomarkers Heart Failure Research 40

Stroke Journal

JANUARY 30, 2025

MicroRNAs (miRs) have been associated with thrombosis and the blood clotting cascade and can provide additional insight about pathogenesis or biomarkers to help establish safe dietary intake guidelines. However, multiomics studies of both xylitol metabolites and these miRs in humans have not been done.

Thrombosis 40

Thrombosis Obesity Strokes Stroke 40

Cardiometabolic Health Congress

OCTOBER 25, 2024

Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I I am very inspired and rejuvenated at the 19th Annual CMHC.

CME 64

CME Innovation Education Atherosclerosis 64

European Journal of Heart Failure

FEBRUARY 12, 2024

Participants with the worst GLS (Q4) were more likely male and of the Black race with a history of tobacco use and diabetes with lower LVEF, higher LV end-diastolic volume, and higher LV mass index. Cumulative incidence of MACE was higher among participants with worse (Q4 vs. Q1) GLS (20.4%

Cardiovascular Disease 40

Cardiovascular Disease Biomarkers Myocardial Infarction Heart Failure 40

DAIC

JANUARY 23, 2024

7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11 7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11 N Engl J Med. 2019;381(26):2497-2505.

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

European Journal of Heart Failure

NOVEMBER 23, 2023

Patients with albuminuria had a more severe cardiac phenotype evidenced by higher serum cardiac biomarkers (median NT-proBNP: 4027ng/L [2173-6889] vs 1851ng/L [997-3209], P<0.001; median troponin-T: 69ng/L [46-101] vs 48ng/L [34-68], P<0.001) and worse echocardiographic indices of systolic (longitudinal strain: -10.0±3.6%

Kidney Disease 40

Kidney Disease Article Biomarkers Heart Failure 40

European Journal of Heart Failure

JANUARY 21, 2024

These differences remained significant even after adjusting for age, gender, body mass index, history of diabetes mellitus, arterial hypertension, and coronary artery disease. Our study showed SGLT2 gene and protein hyper-expression in patients with LF-LG AS, compared to controls and HG AS ( p  < 0.05).

Stenosis 40

Stenosis Aortic Aortic valve Coronary Artery Disease 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

IntroductionThe COVID-19 pandemic, starting in 2020, raised concerns about potential long-term health impacts, including its effects on cardiovascular health and related biomarkers. The prevalence and treatment rates of diabetes, hypertension, and dyslipidemia remained consistent.

COVID-19 52

COVID-19 Blood Pressure Cholesterol Biomarkers 52

Cardiometabolic Health Congress

MARCH 8, 2024

There is increased cognizance of gender inequality and the importance of inclusive and diverse approaches to medical research. Historically, women have been underrepresented in scientific fields, and this spills over into the research and study of women’s health.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59